Pfizer signs $5.3 billion U.S. deal to supply COVID-19 antiviral pills
Pfizer Inc (PFE.N) said on Thursday it had signed a $5.29 billion deal with the U.S. government to deliver 10 million courses of its experimental COVID-19 antiviral...
Pfizer vaccine for children may be ready by Thanksgiving -White House adviser
Pfizer Inc's (PFE.N) new vaccine for children aged five to 11 could be ready as early as November pending approval from federal regulatory health agencies, White House...
Regulators could OK Pfizer boosters for older Americans this week
U.S. regulators could authorize a booster shot of the Pfizer Inc (PFE.N)/BioNTech SE COVID-19 vaccine for older and some high-risk Americans early this week in time...
COVID Vaccine For 12+: 12-15 Years Old Will Be Vaccinated, EMA Approves Pfizer’s Vaccine
The European Medicines Agency (EMA) has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years. The Pfizer BioNotech vaccine was...